登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 7916 条符合本次的查询结果， 用时 1.7732512 秒

81. Department of Error.

来源: Lancet. 2025年405卷10493期1908页

82. Global trends and projections in antimicrobial resistance - Authors' reply.

作者: Tomislav Mestrovic.;Rebecca Hsu.;Lucien Swetschinski.;Christopher J L Murray.;Mohsen Naghavi.
来源: Lancet. 2025年405卷10493期1907-1908页

83. Global trends and projections in antimicrobial resistance.

作者: Vimalraj Selvaraj.;Swathi Sudhakar.;Saravanan Sekaran.
来源: Lancet. 2025年405卷10493期1906-1907页

84. Global trends and projections in antimicrobial resistance.

作者: Sylvia Yang Liu.;Zhuowei Long.;Song Lin Chua.
来源: Lancet. 2025年405卷10493期1906页

85. Global trends and projections in antimicrobial resistance.

作者: Abebaw Fekadu.;Yimtubezinash Woldeamanuel.;Asrat Hailu.;Eyasu Makonnen.
来源: Lancet. 2025年405卷10493期1905-1906页

86. Global trends and projections in antimicrobial resistance.

作者: Edmond Siu-Keung Ma.;Shuk-Ching Wong.;Vincent Chi-Chung Cheng.;Peng Wu.
来源: Lancet. 2025年405卷10493期1904-1905页

87. Global trends and projections in antimicrobial resistance.

作者: Manica Balasegaram.
来源: Lancet. 2025年405卷10493期1904页

88. Prioritising maternal health must include care before pregnancy.

作者: Danielle Schoenaker.;Judith Stephenson.;Sanhita Chakrabarti.;Lara Alloway.;Keith M Godfrey.
来源: Lancet. 2025年405卷10493期1903页

89. Critical factors for improving maternal health.

作者: Mary J Renfrew.;Leslie Altic.;Chris Gale.;Alexander Heazell.;Marian Knight.
来源: Lancet. 2025年405卷10493期1903-1904页

90. Moving from evidence to prioritised action on AMR.

作者: Dominic Moran.;Clare I R Chandler.;Steven Montgomery Laird.;Benjamin J Parcell.;Laura A Richards.;Julie Robotham.
来源: Lancet. 2025年405卷10493期1901页

91. Implementation challenges of personalised phage therapy.

作者: Sarah Djebara.;Rob Lavigne.;Jean-Paul Pirnay.
来源: Lancet. 2025年405卷10493期1901-1903页

92. Safety of low-intensity monitoring after thrombolysis in acute ischaemic stroke.

作者: Susan Ashcraft.
来源: Lancet. 2025年405卷10493期1884-1885页

93. The need to strengthen the US Food and Drug Administration: US cuts threaten health care at home and abroad.

作者: Jayasree K Iyer.
来源: Lancet. 2025年405卷10496期2188-2191页

94. Zackie Achmat: irrepressible health activist.

作者: Sarah Boseley.
来源: Lancet. 2025年

95. Department of Error.

来源: Lancet. 2025年405卷10494期2048页

96. Retraction-Taiwan's national health care on the brink of systemic collapse.

作者: Jing-Xing Li.;Shu-Bai Hsu.
来源: Lancet. 2025年405卷10494期2036页

97. Transcatheter aortic valve implantation: lessons from the ACURATE IDE trial.

作者: Stephan Windecker.;Thomas Pilgrim.
来源: Lancet. 2025年405卷10494期2026-2028页

98. Jacifusen for FUS-ALS: molecular effects and clinical outcomes in a case series.

作者: Naoki Suzuki.;Ayumi Nishiyama.;Satoru Ebihara.;Masashi Aoki.
来源: Lancet. 2025年405卷10494期2028-2030页

99. Antisense oligonucleotide jacifusen for FUS-ALS: an investigator-initiated, multicentre, open-label case series.

作者: Neil A Shneider.;Matthew B Harms.;Vlad A Korobeynikov.;Olivia M Rifai.;Benjamin N Hoover.;Elizabeth A Harrington.;Sonya Aziz-Zaman.;Jessica Singleton.;Arish Jamil.;Vikram R Madan.;Ikjae Lee.;Jinsy A Andrews.;Richard M Smiley.;Mahabub M Alam.;Lauren E Black.;Minwook Shin.;Jonathan K Watts.;David Walk.;Daniel Newman.;Robert M Pascuzzi.;Markus Weber.;Christoph Neuwirth.;Sandrine Da Cruz.;Armand Soriano.;Roger Lane.;Scott Henry.;Joel Mathews.;Paymaan Jafar-Nejad.;Dan Norris.;Frank Rigo.;Robert H Brown.;Stephan Miller.;Rebecca Crean.;C Frank Bennett.
来源: Lancet. 2025年405卷10494期2075-2086页
Pathogenic variants of fused in sarcoma (FUS) cause amyotrophic lateral sclerosis (FUS-ALS), with evidence of gain of function. Jacifusen is an antisense oligonucleotide targeting FUS pre-mRNA, previously shown to delay neurodegeneration in a mouse model and potentially slow functional decline in a first-in-human study. Here, we sought to further evaluate use of jacifusen as a treatment for FUS-ALS.

100. The weaponisation of water.

作者: Rebecca Sers.
来源: Lancet. 2025年
共有 7916 条符合本次的查询结果， 用时 1.7732512 秒